SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017819
Filing Date
2022-11-14
Accepted
2022-11-14 16:52:06
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220930x10q.htm   iXBRL 10-Q 1989655
2 EX-31.1 tmb-20220930xex31d1.htm EX-31.1 16501
3 EX-31.2 tmb-20220930xex31d2.htm EX-31.2 13466
4 EX-32.1 tmb-20220930xex32d1.htm EX-32.1 7670
5 EX-32.2 tmb-20220930xex32d2.htm EX-32.2 6983
  Complete submission text file 0001558370-22-017819.txt   6792982

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220930.xsd EX-101.SCH 46003
7 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 45351
8 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 232034
9 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 324758
10 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 341094
60 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930x10q_htm.xml XML 1053690
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 221386993
SIC: 2834 Pharmaceutical Preparations